Objective: Although asthma is highly prevalent among certain Hispanic subgroups, genetic determinants of asthma and asthma-related traits have not been conclusively identified in Hispanic populations. Therefore, we sought to identify genomic regions containing susceptibility loci for pulmonary function and bronchodilator response (BDR) in Costa Ricans.
Methods: Eight extended pedigrees were ascertained through schoolchildren with asthma in the Central Valley of Costa Rica. Short-tandem repeat (STR) markers were genotyped throughout the genome at an average spacing of 8.2 cM. Multipoint variance component linkage analyses of FEV1 and FEV1/FVC (both pre- and post-bronchodilator) and BDR were performed in these eight families (pre-bronchodilator spirometry, N=640; post-bronchodilator spirometry and BDR, N=624). Nine additional STR markers were genotyped on chromosome 7. Secondary analyses were repeated after stratification by cigarette smoking.
Results: Among all subjects, the highest logarithm of the odds of linkage (LOD) score for FEV1 (post-bronchodilator) was found on chromosome 7q34-35 (LOD=2.45, including the additional markers). The highest LOD scores for FEV1/FVC (pre-bronchodilator) and BDR were found on chromosomes 2q (LOD=1.53) and 9p (LOD=1.53), respectively. Among former and current smokers, there was near-significant evidence of linkage to FEV1/FVC (post-bronchodilator) on chromosome 5p (LOD=3.27) and suggestive evidence of linkage to FEV1 on chromosomes 3q (pre-bronchodilator, LOD=2.74) and 4q (post-bronchodilator, LOD=2.66).
Conclusions: In eight families of children with asthma in Costa Rica, there is suggestive evidence of linkage to FEV1 on chromosome 7q34-35. In these families, FEV1/FVC may be influenced by an interaction between cigarette smoking and a locus (loci) on chromosome 5p.
- bronchodilator agents